La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Viking Holdings a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Viking Holdings..

Viking Holdings (NYSE:VIK) Azioni, Catena delle Opzioni

Viking Holdings

Viking Holdings Ltd is a travel company, with a fleet of 92 small, state-of-the-art ships, which view as floating hotels. It offer travel experiences on all seven continents in all three categories of the cruise industry—river, ocean and expedition cruising. The Group defines its products based on the type of cruise offering and language of the cruise service. The River segment provides river cruises outside the United States to English-speaking passengers. The Ocean segment provides ocean cruises to English-speaking passengers. Other includes operating segments that are not individually reportable, consisting of expedition cruises for English-speaking passengers ("Expedition"), Mississippi River cruises for English-speaking passengers, Viking China, which includes cruises for Mandarin.

Viking Holdings Ltd

VIKASA SPAC Series I Acquisition Corp

VIKING THERAPEUTICS ORD

Viking Energy Group Inc

Viking Line Abp

Viking Therapeutics Inc

<p>Truist Securities  analyst Neal Dingmann   maintains Riley Exploration Permian (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/REPX#AMEX">REPX</a>) with a Buy and raises the price target from $38 to $40.</p>


News

Price Target

Analyst Ratings

REPX

Truist Securities Maintains Buy on Riley Exploration Permian, Raises Price Target to $40

<p>Over the past 24 hours, <strong>Kaspa's</strong> (CRYPTO:KAS) price has fallen 4.46% to <strong>$0.11</strong>. This continues its negative trend over the past week where it has experienced a 4.0% loss, moving from $0.12 to its current price. </p>
<p>The chart below compares the price movement and volatility for Kaspa over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078208_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has fallen 3.0% over the past week, moving in tandem, directionally, with the overall circulating supply of the coin, which has decreased 0.02%. This brings the circulating supply to 25.11 billion, which makes up an estimated 87.48% of its max supply of 28.70 billion. According to our data, the current market cap ranking for KAS is #41 at $2.81 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078208_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

Movers

Trading Ideas

Cryptocurrency Kaspa Decreases More Than 4% Within 24 hours

WIIM

Red Rock Resorts shares are trading lower after the company reported worse-than-expected Q3 adjusted EPS results.

Ziff Davis shares are trading higher after the company reported better-than-expected Q3 financial results.

<p><strong>Mineralys Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) is set to give its latest quarterly earnings report on Monday, 2024-11-11. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Mineralys Therapeutics will report an <strong>earnings per share</strong> (EPS) of $-0.83. </p>
<p>Anticipation surrounds Mineralys Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company missed EPS by $0.13, which was followed by a 22.82% drop in the share price the next day.</p>
<p>Here's a look at Mineralys Therapeutics's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.70</td>
<td>-0.67</td>
<td>-0.82</td>
<td>-0.76</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.83</td>
<td>-0.70</td>
<td>-0.61</td>
<td>-0.57</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-23.0%</td>
<td>-5.0%</td>
<td>-2.0%</td>
<td>-7.000000000000001%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078160_0.png" alt="eps graph" /></p>
<h3>Performance of Mineralys Therapeutics Shares</h3>
<p>Shares of Mineralys Therapeutics were trading at $14.16 as of November 07. Over the last 52-week period, shares are up 124.06%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MLYS/earnings"><strong>To track all earnings releases for Mineralys Therapeutics visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

MLYS

Insights into Mineralys Therapeutics's Upcoming Earnings

<p>Truist Securities  analyst Jailendra Singh   maintains Privia Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVA#NASDAQ">PRVA</a>) with a Buy and raises the price target from $24 to $27.</p>


PRVA

Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $27

<p>Live Nation Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) will release its quarterly earnings report on Monday, 2024-11-11. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Live Nation Entertainment to report an <strong>earnings per share</strong> (EPS) of $1.71.</p>
<p>Live Nation Entertainment bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company missed EPS by $0.04, which was followed by a 1.66% increase in the share price the next day.</p>
<p>Here's a look at Live Nation Entertainment's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.07</td>
<td>-0.19</td>
<td>-1.03</td>
<td>1.27</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.03</td>
<td>-0.53</td>
<td>-1.22</td>
<td>1.78</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>2.0%</td>
<td>7.000000000000001%</td>
<td>2.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078152_0.png" alt="eps graph" /></p>
<h3>Tracking Live Nation Entertainment's Stock Performance</h3>
<p>Shares of Live Nation Entertainment were trading at $124.6 as of November 07. Over the last 52-week period, shares are up 40.23%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/LYV/earnings"><strong>To track all earnings releases for Live Nation Entertainment visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What's Next: Live Nation Entertainment's Earnings Preview

<p>Gatos Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATO#NYSE">GATO</a>) is gearing up to announce its quarterly earnings on Monday, 2024-11-11. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Gatos Silver will report an <strong>earnings per share</strong> (EPS) of $0.14.</p>
<p>The market awaits Gatos Silver's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS missed by $0.02, leading to a 6.65% drop in the share price on the subsequent day.</p>
<p>Here's a look at Gatos Silver's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.15</td>
<td>0.02</td>
<td>0.09</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.13</td>
<td>0.04</td>
<td>0.18</td>
<td>0.05</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-7.000000000000001%</td>
<td>2.0%</td>
<td>-1.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078145_0.png" alt="eps graph" /></p>
<h3>Performance of Gatos Silver Shares</h3>
<p>Shares of Gatos Silver were trading at $17.03 as of November 07. Over the last 52-week period, shares are up 244.1%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/GATO/earnings"><strong>To track all earnings releases for Gatos Silver visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


GATO

Gatos Silver Earnings Preview

<p>Over the past 24 hours, <strong>Internet Computer's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">ICP</a>) price has risen 3.8% to <strong>$7.87</strong>. This is contrary to its negative trend over the past week where it has experienced a 1.0% loss, moving from $8.01 to its current price. As it stands right now, <strong>the coin's all-time high is $700.65</strong>. </p>
<p>The chart below compares the price movement and volatility for Internet Computer over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078139_0.png" alt="price_chart" /></p>
<p>Internet Computer's trading volume has climbed 57.0% over the past week, moving in tandem, directionally, with the overall circulating supply of the coin, which has increased 0.59%. This brings the circulating supply to 473.94 million. According to our data, the current market cap ranking for ICP is #30 at $3.73 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078139_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$ICP

Cryptocurrency Internet Computer Up More Than 3% In 24 hours

<p>Over the past 24 hours, <strong>NEAR Protocol's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/near/usd">NEAR</a>) price has risen 3.95% to <strong>$4.29</strong>. This continues its positive trend over the past week where it has experienced a 7.0% gain, moving from $4.08 to its current price. As it stands right now, <strong>the coin's all-time high is $20.44</strong>. </p>
<p>The chart below compares the price movement and volatility for NEAR Protocol over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078129_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has increased 41.0% over the past week, while the overall circulating supply of the coin has decreased 0.24%. The current market cap ranking for NEAR is #26 at $5.26 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078129_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$NEAR

Cryptocurrency NEAR Protocol Rises More Than 3% In 24 hours

<p>Bioceres Crop Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOX#NASDAQ">BIOX</a>) is gearing up to announce its quarterly earnings on Monday, 2024-11-11. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Bioceres Crop Solutions will report an <strong>earnings per share</strong> (EPS) of $0.09.</p>
<p>Bioceres Crop Solutions bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company missed EPS by $0.27, leading to a 13.41% drop in the share price the following trading session.</p>
<p>Here's a look at Bioceres Crop Solutions's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.24</td>
<td>0.170</td>
<td>0.09</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.03</td>
<td>0.139</td>
<td>0.02</td>
<td>-0.04</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-13.0%</td>
<td>-3.0%</td>
<td>7.000000000000001%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078126_0.png" alt="eps graph" /></p>
<h3>Market Performance of Bioceres Crop Solutions's Stock</h3>
<p>Shares of Bioceres Crop Solutions were trading at $6.57 as of November 07. Over the last 52-week period, shares are down 38.27%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analysts' Take on Bioceres Crop Solutions</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Bioceres Crop Solutions.</p>
<p>The consensus rating for Bioceres Crop Solutions is Buy, derived from 6 analyst ratings. An average one-year price target of $12.92 implies a potential 96.65% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Intrepid Potash, FMC and Mosaic, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Intrepid Potash is maintaining an Sell status according to analysts, with an average 1-year price target of $19.0, indicating a potential 189.19% upside.</li>
<li>The prevailing sentiment among analysts is an Neutral trajectory for FMC, with an average 1-year price target of $69.25, implying a potential 954.03% upside.</li>
<li>The prevailing sentiment among analysts is an Neutral trajectory for Mosaic, with an average 1-year price target of $29.4, implying a potential 347.49% upside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>The peer analysis summary outlines pivotal metrics for Intrepid Potash, FMC and Mosaic, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bioceres Crop Solutions</td>
<td>Buy</td>
<td>18.31%</td>
<td>$46.66M</td>
<td>-0.49%</td>
</tr>
<tr>
<td>Intrepid Potash</td>
<td>Sell</td>
<td>5.66%</td>
<td>$7.73M</td>
<td>-0.27%</td>
</tr>
<tr>
<td>FMC</td>
<td>Neutral</td>
<td>8.50%</td>
<td>$386.40M</td>
<td>1.41%</td>
</tr>
<tr>
<td>Mosaic</td>
<td>Neutral</td>
<td>-17.01%</td>
<td>$394M</td>
<td>-1.36%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Bioceres Crop Solutions ranks highest in Revenue Growth among its peers. It has the highest Gross Profit margin. However, it has the lowest Return on Equity.</p>
<h3>Unveiling the Story Behind Bioceres Crop Solutions</h3>
<p>Bioceres Crop Solutions Corp is a fully-integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. The business divisions consist of crop protection, seed and integrated products, and crop nutrition. The company derives majority of its revenue from the crop protection division. Its product includes fertilizers, inoculants, adjuvants, crop protection solutions and seeds.</p>
<h3>Bioceres Crop Solutions's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Bioceres Crop Solutions's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of <strong>18.31%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Bioceres Crop Solutions's net margin excels beyond industry benchmarks, reaching <strong>-1.23%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Bioceres Crop Solutions's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>-0.49%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Bioceres Crop Solutions's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-0.18%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>0.86</strong>, caution is advised due to increased financial risk.</p>
<p><a href="https://www.benzinga.com/quote/BIOX/earnings"><strong>To track all earnings releases for Bioceres Crop Solutions visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


BIOX

Examining the Future: Bioceres Crop Solutions's Earnings Outlook

Sweetgreen shares are trading lower after Goldman Sachs downgraded the stock from Buy to Neutral.

<p>RMR Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMR#NASDAQ">RMR</a>) will release its quarterly earnings report on Monday, 2024-11-11. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate RMR Gr to report an <strong>earnings per share</strong> (EPS) of $0.38.</p>
<p>RMR Gr bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company missed EPS by $0.02, which was followed by a 0.95% drop in the share price the next day.</p>
<p>Here's a look at RMR Gr's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.39</td>
<td>0.40</td>
<td>0.45</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.37</td>
<td>0.39</td>
<td>0.49</td>
<td>0.48</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>-3.0%</td>
<td>4.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078118_0.png" alt="eps graph" /></p>
<h3>RMR Gr Share Price Analysis</h3>
<p>Shares of RMR Gr were trading at $24.44 as of November 07. Over the last 52-week period, shares are up 6.62%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/RMR/earnings"><strong>To track all earnings releases for RMR Gr visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: RMR Gr's Earnings Preview

<p>Global Ship Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) is gearing up to announce its quarterly earnings on Monday, 2024-11-11. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Global Ship Lease will report an <strong>earnings per share</strong> (EPS) of $2.47.</p>
<p>Investors in Global Ship Lease are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.17, leading to a 6.39% increase in the share price the following trading session.</p>
<p>Here's a look at Global Ship Lease's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.29</td>
<td>2.27</td>
<td>2.35</td>
<td>2.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.46</td>
<td>2.53</td>
<td>2.49</td>
<td>2.33</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>6.0%</td>
<td>2.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078112_0.png" alt="eps graph" /></p>
<h3>Performance of Global Ship Lease Shares</h3>
<p>Shares of Global Ship Lease were trading at $24.73 as of November 07. Over the last 52-week period, shares are up 41.52%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/GSL/earnings"><strong>To track all earnings releases for Global Ship Lease visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What to Expect from Global Ship Lease's Earnings

<p>Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) is preparing to release its quarterly earnings on Monday, 2024-11-11. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Sapiens Intl Corp to report an <strong>earnings per share</strong> (EPS) of $0.38.</p>
<p>The market awaits Sapiens Intl Corp's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS beat by $0.01 in the last quarter, leading to a 1.16% drop in the share price on the following day.</p>
<p>Here's a look at Sapiens Intl Corp's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.36</td>
<td>0.34</td>
<td>0.34</td>
<td>0.34</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.37</td>
<td>0.36</td>
<td>0.36</td>
<td>0.34</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>2.0%</td>
<td>1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078104_0.png" alt="eps graph" /></p>
<h3>Performance of Sapiens Intl Corp Shares</h3>
<p>Shares of Sapiens Intl Corp were trading at $39.48 as of November 07. Over the last 52-week period, shares are up 56.05%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/SPNS/earnings"><strong>To track all earnings releases for Sapiens Intl Corp visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


SPNS

Earnings Outlook For Sapiens Intl Corp

<p>Benchmark  analyst Daniel Kurnos   maintains Vivid Seats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAT#NASDAQ">SEAT</a>) with a Buy and lowers the price target from $10 to $8.</p>


SEAT

Benchmark Maintains Buy on Vivid Seats, Lowers Price Target to $8

<p>Scotiabank  analyst Sung Ji Nam   maintains Veracyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCYT#NASDAQ">VCYT</a>) with a Sector Outperform and raises the price target from $40 to $44.</p>


VCYT

Scotiabank Maintains Sector Outperform on Veracyte, Raises Price Target to $44

<p>Truist Securities  analyst Mark Hughes   maintains Primerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>) with a Buy and raises the price target from $300 to $340.</p>


Truist Securities Maintains Buy on Primerica, Raises Price Target to $340

<p>VAALCO Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGY#NYSE">EGY</a>) will release its quarterly earnings report on Monday, 2024-11-11. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate VAALCO Energy to report an <strong>earnings per share</strong> (EPS) of $0.17.</p>
<p>The announcement from VAALCO Energy is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS beat by $0.09 in the last quarter, leading to a 8.38% increase in the share price on the following day.</p>
<p>Here's a look at VAALCO Energy's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.13</td>
<td>0.20</td>
<td>0.12</td>
<td>0.20</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.22</td>
<td>0.06</td>
<td>0.37</td>
<td>0.07</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>8.0%</td>
<td>-4.0%</td>
<td>20.0%</td>
<td>-7.000000000000001%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078098_0.png" alt="eps graph" /></p>
<h3>Market Performance of VAALCO Energy's Stock</h3>
<p>Shares of VAALCO Energy were trading at $5.6 as of November 07. Over the last 52-week period, shares are up 35.52%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/EGY/earnings"><strong>To track all earnings releases for VAALCO Energy visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What's Next: VAALCO Energy's Earnings Preview

<p>Assured Guaranty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGO#NYSE">AGO</a>) will release its quarterly earnings report on Monday, 2024-11-11. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Assured Guaranty to report an <strong>earnings per share</strong> (EPS) of $1.36.</p>
<p>The announcement from Assured Guaranty is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS beat by $0.11 in the last quarter, leading to a 2.37% drop in the share price on the following day.</p>
<p>Here's a look at Assured Guaranty's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.33</td>
<td>1.32</td>
<td>1.18</td>
<td>1.05</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.44</td>
<td>1.96</td>
<td>5.75</td>
<td>3.42</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>5.0%</td>
<td>11.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731078090_0.png" alt="eps graph" /></p>
<h3>Market Performance of Assured Guaranty's Stock</h3>
<p>Shares of Assured Guaranty were trading at $86.53 as of November 07. Over the last 52-week period, shares are up 33.43%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/AGO/earnings"><strong>To track all earnings releases for Assured Guaranty visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights into Assured Guaranty's Upcoming Earnings

Barclays raised the firm's price target on Viking Holdings (VIK) to $43 from $39 and keeps an Overweight rating on the shares as part of a Q3 earni...

Viking Holdings price target raised to $43 from $39 at Barclays

Barclays analyst Brandt Montour maintained a Buy rating on Viking Holdings Ltd (VIK – Research Report) today and set a price target of $43.00. The ...

Viking Holdings Ltd (VIK) Receives a Buy from Barclays

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Viking Holdings</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/vik-stock-quote/"><strong>VIK</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Viking Holdings reported earnings per share of 37 cents. This was below the analyst estimate for EPS of 65 cents.</li><li>The company reported revenue of $1.59 billion.</li><li>This was 10.98% better than the analyst estimate for revenue of $1.43 billion.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div>	<p>The post <a href="https://investorplace.com/earning-results/2024/08/vik-stock-earnings-viking-holdings-for-q2-of-2024/">VIK Stock Earnings: Viking Holdings Misses EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

VIK Stock Earnings: Viking Holdings Misses EPS, Beats Revenue for Q2 2024

Catalyst Watch: Eyes on tech with Apple, Amazon, Alphabet, and Meta reporting

IPO Roundup: Brazil Potash, Septerna and more

Royal Caribbean Q4 guidance reflects impact from Hurricane Milton

The Momentum Weekly - On The Cusp Of The Election

AAPL

ACTHF

AMZN

BMEA

CAKR

CASK

CHTR

CUPR

DASH

DUOL

FBGL

FFIV

FMFC

FUTU

FVRR

GELS

GOOG

HSBC

IDCC

INGM

INTC

INUV

LFVN

LMND

MGPI

MRNS

MSFT

NCLH

OSTX

PAPL

PHUN

PTON

QRVO

RBLX

RDDT

RKLB

RMLFF

SABR

SAVE

SBUX

SNAP

SVCO

TDACU

TLTFF

TSLA

UBER

WHLR

XPEV

Press Releases

Viking Takes Delivery of Newest Egypt Ship

Viking Reports Second Quarter 2024 Financial Results

Viking Announces Expansion of China Offering with New Voyages Starting in 2025

Viking Announces Launch of Secondary Public Offering

Viking Announces Pricing of its Secondary Offering

Viking Celebrates Historic Return to China

Condé Nast Traveler Readers Name Viking #1 for Rivers, #1 for Oceans and #1 for Expeditions for Second Consecutive Year

Viking Schedules Conference Call on Third Quarter 2024 Financial Results

Viking Names Two Newest Nile River Ships in Luxor

Airbnb

Atour Lifestyle Holdings Limited - American Depositary Shares

Atour Lifestyle Holdings

Booking Holdings

Choice Hotels International, Inc. Common Stock

Choice Hotels Intl

Despegar.com

Expedia Group

Global Business Travel Group, Inc. Class A Common Stock

Global Business Travel

GreenTree Hospitality Group Ltd. American depositary shares, each representing one Class A ordinary share

GreenTree Hospitality Gr

Hyatt Hotels Corporation Class A Common Stock

Hyatt Hotels

Hilton Grand Vacations

Hilton Worldwide Holdings Inc. Common Stock

Hilton Worldwide Holdings

H World Group Limited - American Depositary Shares

H World Group

Intercontinental Hotels Group American Depositary Shares (Each representing one Ordinary Share)

Comments

Viking Holdings

Viking Holdings (VIK) Opzioni

Viking Holdings (NYSE:VIK) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO